Derm-Biome Pharmaceuticals, Inc

About:

Derm-Biome Pharmaceuticals is a biopharmaceutical company focused on developing treatments for skin diseases and conditions. .

Website: https://derm-biomepharmaceuticals.com/

Twitter/X: dermbiome/

Top Investors: National Research Council of Canada Industrial Research Assistance Program, Natural Sciences and Engineering Research Council of Canada (NSERC)

Description:

Derm-Biome is focused on advancing safe, well-tolerated, and highly effective topical treatments for inflammatory skin diseases (acne, atopic dermatitis), precancerous skin conditions, and aging skin/longevity.

Total Funding Amount:

$1.52M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Vancouver, British Columbia, Canada

Founded Date:

2018-04-17

Contact Email:

geberwein(AT)derm-biome.com

Founders:

Gordon Eberwein, Poul Sorensen

Number of Employees:

1-10

Last Funding Date:

2024-05-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai